Effects of epsilon-aminocaproylaminoacids on prothrombin activation and thrombin activity
Midura-Nowaczek, K.; Roszkowska-Jakimiec, W.; Bruzgo, I.; Worowski, K.
Materia Medica Polona. Polish Journal of Medicine and Pharmacy 30(1-2): 3-5
1998
ISSN/ISBN: 0025-5246 PMID: 10214467 Document Number: 496302
Influence of four epsilon-aminocaproylaminoacids on prothrombin activation and thrombin activity was examined. Only epsilon-aminocaproylnorleucine markedly inhibited the prothrombin activation in an extrinsic system.
Document emailed within 1 workday
Related Documents
Momi, S.; Nasimi, M.; Colucci, M.; Nenci, G.G.; Gresele, P. 2001: Low molecular weight heparins prevent thrombin-induced thrombo-embolism in mice despite low anti-thrombin activity. Evidence that the inhibition of feed-back activation of thrombin generation confers safety advantages over direct thrombin inhibition Haematologica 86(3): 297-302Prasa, D.; Svendsen, L.; Stürzebecher, J. 1997: The ability of thrombin inhibitors to reduce the thrombin activity generated in plasma on extrinsic and intrinsic activation Thrombosis and Haemostasis 77(3): 498-503
Fukutake, K.; Mimura, K.; Shinozawa, K.; Fujiwara, K.; Kobayashi, T.; Yatsuhashi, T.; Fukutake, K.; Inaba, H. 1989: Effects of ulinastatin on alpha-thrombin and the activation of protein C and factor XIIi induced by thrombin Rinsho Byori. Japanese Journal of Clinical Pathology 37(4): 416-420
Leroy-Matheron, C.; Gouault-Heilmann, M. 1994: Influence of conditions of blood sampling on coagulation activation markers (prothrombin fragment 1 + 2, thrombin-antithrombin complexes and D-dimers) measurements Thrombosis Research 74(4): 399-407
Kienast, J.; Thompson, S.G.; Raskino, C.; Pelzer, H.; Fechtrup, C.; Ostermann, H.; van de Loo, J. 1993: Prothrombin activation fragment 1 + 2 and thrombin antithrombin III complexes in patients with angina pectoris: relation to the presence and severity of coronary atherosclerosis Thrombosis and Haemostasis 70(4): 550-553
Pajdak, W.; Radwan, J.; Guzik, T.J. 2004: Cleavage of prothrombin bound in immune complexes results in high thrombin enzymatic activity Journal of Physiology and Pharmacology: An Official Journal of the Polish Physiological Society 55(2): 477-484
Takeda, Y. 1970: Studies of the effects of heparin, Coumadin, and vitamin K on prothrombin metabolism and distribution in calves with the use of iodine-125-prothrombin. Characterization of the prothrombin system Journal of Laboratory and Clinical Medicine 75(3): 355-381
Ibbotson, S.H.; Tate, G.M.; Davies, J.A. 1992: Thrombin activity by intrinsic activation of plasma in-vitro accelerates with increasing age of the donor Thrombosis and Haemostasis 67(3): 377-380
Suzuki, K. 1988: Gene structure of human thrombomodulin, a thrombin receptor on endothelium acting as a cofactor for thrombin-catalyzed activation of protein C Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 51(8): 1655-1664
Marcelletti, J.F.; Katz, D.H. 1984: FcR epsilon+ lymphocytes and regulation of the IgE antibody system. III. Suppressive factor of allergy (SFA) is produced during the in vitro FcR epsilon expression cascade and displays corollary physiologic activity in vivo Journal of Immunology 133(6): 2837-2844
Jamieson, G.A. 1988: The activation of platelets by thrombin: a model for activation by high and moderate affinity receptor pathways Progress in Clinical and Biological Research 283: 137-158
Berg, W.; Hillvärn, B.; Arwin, H.; Stenberg, M.; Lundström, I. 1979: The isoelectric point of thrombin and its behaviour compared to prothrombin at some solid surfaces Thrombosis and Haemostasis 42(3): 972-982
Vinogradova, S.V. 2006: The role of epsilon 2/epsilon 3/epsilon 4 polymorphism of the apolipoprotein e gene in the development of dislipoproteinemia and its influence on the efficacy of the hypolipidemic therapy Tsitologiia i Genetika 40(6): 59-72
Te Velde, A.A.; Rousset, F.; Peronne, C.; De Vries, J.E.; Figdor, C.G. 1990: IFN-alpha and IFN-gamma have different regulatory effects on IL-4-induced membrane expression of Fc epsilon RIIb and release of soluble Fc epsilon RIIb by human monocytes Journal of Immunology 144(8): 3052-3059
Rifón, J.; Collados, M.T.; Montes, R.; Chordá, C.; Páramo, J.A.; Rocha, E. 1992: Thrombin-antithrombin complexes and F1+2 prothrombin fragment in coronary revascularization surgery. Relationship with graft occlusion Sangre 37(4): 259-263
Cros, G.H.; Chaptal, P.A.; Serrano, J.J. 1987: The effects of trypsin, plasmin, chymotrypsin and thrombin on human heart adenylate cyclase activity Research Communications in Chemical Pathology and Pharmacology 57(2): 277-280
Seiler, S.M.; Peluso, M.; Tuttle, J.G.; Pryor, K.; Klimas, C.; Matsueda, G.R.; Bernatowicz, M.S. 1996: Thrombin receptor activation by thrombin and receptor-derived peptides in platelet and CHRF-288 cell membranes: receptor-stimulated GTPase and evaluation of agonists and partial agonists Molecular Pharmacology 49(1): 190-197
Sakuragawa, N. 1974: Prothrombin activation mechanism Nihon Rinsho. Japanese Journal of Clinical Medicine 32(5): 901-909
Jurd, K.M.; Gibbs, R.V.; Hunt, B.J. 1996: Activation of human prothrombin by porcine endothelium Transplantation Proceedings 28(2): 610
Ono, M.; Ohta, H.; Ohhira, M.; Sekiya, C.; Namiki, M. 1990: Measurement of immunoreactive prothrombin, des-gamma-carboxy prothrombin, and vitamin K in human liver tissues: overproduction of immunoreactive prothrombin in hepatocellular carcinoma American Journal of Gastroenterology 85(9): 1149-1154